Food is medicine, and nothing is safe from politics. Freedom of choice is only free when the game isn’t rigged and the marginalized aren’t used as pawns.

The pro-life paradox by the numbers.

Join me and make a gift to Give Day 2023 #SHCGiveDay givecampus.com/wp0zqx

Free Article Publishing Charge (APC) alert 🔔🚨 Follow @GynOncJnls during the SGO Annual Meeting #SGO2023 #SGOMtg and have a chance to win an APC waiver for #GynOncReports ☀️ 🏝️ #Tampa

Yesterday, Alabama's Department of Health announced a plan to eliminate cervical cancer in the state. Currently, Alabama ranks 5th worst in the US for new cervical cancer cases. al.com/news/2023/05/a…

How do we mobilize the incredible oncology community we have here to get more #carboplatin and #cisplatin? We need mass production of these life saving chemotherapy drugs.#MedTwitter #gyncsm #chemotherapy

This is a major issue, with life-saving systemics like methotrexate & cisplatin in short supply. Interruption in therapy is a threat to positive outcomes. We American Cancer Society Cancer Action Network urge Congress to identify durable solutions that change the fundamental underpinnings of cancer drug shortages!

America has the highest maternal mortality rate among developed nations–and it’s on the rise. Here’s why we are facing a pregnancy health crisis apple.news/A530g80paTR-F3…

The SGO, FdtnForWomensCancer and The GOG Foundation Inc. partners endorsed a recent NRG Oncology Oncology statement to member institutions regarding management of platinum-based therapies on clinical trials during chemotherapy drug shortages.

Great job Amanda Nickles Fader, MD getting this important message out!! We need to continue to work together to prevent chemotherapy shortages from even occurring #nopatientleftbehind x.com/cnnthismorning…

Great job Amanda Nickles Fader, MD!! Thank you for all that you are doing for our patients

SGO The GOG Foundation Inc. FdtnForWomensCancer supporting gyn onc patients and providers through chemotherapy shortage guidelines and advocacy. Thank you ASCO for the endorsement. Working together to ensure #nopatientleftbehind - the Power of Shared Purpose

⭐️ASCO’s Julie Gralow: At least 100,000 (and up to 500,000) cancer patients affected by cisplatin, carboplatin shortage ASCO Julie Gralow OncoAlert cancerletter.com/conversation-w…

The Cancer Letter cancerletter.com/conversation-w…

The era of radical cervical cancer frontline hysterectomy ends as #SHAPE trial randomization of simple vs radical hyst 1A2-1B1 (<2cm) confirms non-inferiority of a 3yr pelvic recurrence rate and 2ndary endpts PFS/OS are met #ASCO2023 Moffitt Cancer Center MoffittGYNONC

#relationshipgoals #ASCO2023 Thank you for your leadership and sharing your humanity with us Eric J. Small, MD, FASCO

NCCN’s clinical practice guidelines for ovarian cancer have been updated to approve oxaliplatin-based regimens for use in special circumstances, including the current shortage of carboplatin and cisplatin in the United States. Learn more at bit.ly/3NsS1ua. #GynCSM National Comprehensive Cancer Network (NCCN)

Physician-scientists are a dying breed going from 4.7% in '80s to ~1.5% today. Multiple factors contribute including flat/declining #NIH funding. Translational research is critical for advancing clinical care. jamanetwork.com/journals/jaman…

The